Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02102074
Other study ID # 0036
Secondary ID
Status Recruiting
Phase N/A
First received February 7, 2013
Last updated December 9, 2014
Start date May 2012
Est. completion date May 2015

Study information

Verified date February 2013
Source Meir Medical Center
Contact Shmuel Avital, M.D., Dr.
Phone 972-9-7472162
Email avitalshmuel@gmail.com
Is FDA regulated No
Health authority Israel: Ministry of Health
Study type Observational

Clinical Trial Summary

The investigators hypothesize that the presence of tumor cells and tumor markers in peritoneal cavity are indicative for peritoneal spread during surgery, and may serve as early markers for systemic and/or intra-peritoneal recurrence of the disease and ultimately improve our understanding of tumor spread and disease recurrence.


Recruitment information / eligibility

Status Recruiting
Enrollment 70
Est. completion date May 2015
Est. primary completion date December 2014
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- colon and rectal cancer

Exclusion Criteria:

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms

  • Tumor Cells and Tumor Markers in Peritoneal Cavity

Locations

Country Name City State
Israel Meir Medical Center Kfar-Saba
Israel Meir medical center Kfar-Saba

Sponsors (1)

Lead Sponsor Collaborator
Meir Medical Center

Country where clinical trial is conducted

Israel, 

Outcome

Type Measure Description Time frame Safety issue
Primary tumor cells and tumor markers 2 years No
Secondary Cytokine levels in the abdomen 2 years No